Do you suffer from diabetes and diabetes-related pain in the lower limbs?
Richmond Pharmacology is conducting a clinical trial for a new experimental drug called ABT-639. ABT-639 is a calcium channel blocker being developed for the treatment of diabetic peripheral neuropathy, which is damage to nerves of the peripheral nervous system (the part of the nervous system that connects the brain and spinal cord to the limbs and organs).
The trial is being conducted at Richmond Pharmacology only.
To qualify for participation in this study you need to:
- Be aged between 18 and 75 years (inclusive) at screening
- Have a documented diagnosis of diabetes mellitus type 1 or type 2
- Have presence of diabetes-related pain in the lower limbs of the body
- Be able to communicate well with the Investigator in English, and to understand and fully comply with the requirements of the trial
Other restrictions and exclusions apply – please ask for details.
What’s in it for you?
Apart from helping medical research, we will also compensate you for your time and inconvenience in the form of a monetary payment.
You will receive up to Â£460 for your time on completion of the study.Register for this clinical trial
Want to find out more?
If you are interested in finding out more please send your full name, contact telephone number and email address to email@example.com
Call us on 020 8664 5200 (select option 1) and speak to a member of our Volunteer Recruitment Team.
A detailed information sheet is available on request.
Ref: ABT_DEC 2011